New Standard of care Treatment for EGFR Exon 20 Non-small cell Lung Cancer | Dr. Alexander Spira

Current and Future Management of Non-Small Cell Lung Cancer with an EGFR MutationПодробнее

What I Tell My Patients: Non-Small Cell CancerПодробнее

Second line treatment in activating EGFR non-small cell lung cancer, MARIPOSA - 2 | Onc BrothersПодробнее

ESMO 2023 Lung Cancer - Chapter 2 Highlights – PAPILLON, MARIPOSA, MARIPOSA-2, LIBRETTO-431Подробнее

ASCO 2020: Latest developments in EGFR-mutated non-small cell lung cancerПодробнее